SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Syndax Pharmaceuticals Q4 EPS $(0.44) Misses $(0.43) Estimate, Sales $380K Beat $370K Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 37.14 percent increase over losses of $(0.7) per share

Benzinga · 03/03/2020 21:14

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 37.14 percent increase over losses of $(0.7) per share from the same period last year. The company reported quarterly sales of $380 thousand which beat the analyst consensus estimate of $370 thousand by 2.70 percent. This is the same as the same period last year.